Vous êtes sur la page 1sur 26

Healthcare-Associated

Infection Surveillance

Indonesia
December 18, 2012

© Joint Commission International


1
What is surveillance?

 Continuous systematic collection of data on illness in a


defined population

 Uses standard definitions for the outcome of interest;


e.g., infection, sharps injuries, employee illness

 Involves analysis, interpretation, & dissemination of


data for the purpose of improving health & preventing
disease

© Joint Commission International


2
Surveillance
 Active surveillance
– Proactive approaches such
• Concurrent monitoring of the patients with a
central line and urinary catheter and/or on the
ventilator
• Reviewing important culture results generated by
various microbiology laboratories (local, regional,
national, and international) daily
• Walk-around or surveillance rounds
• Surveillance cultures of targeted patients to plan

© Joint Commission International


a preemptive IPC plans: Examples-MRSA,
MDROs.
3
Surveillance
 Active surveillance (cont’d)
 Reviewing daily census in AM
 Environment of Care (EOC) rounds
 Hand hygiene compliance monitoring
 Reviewing all patients in isolation
 Outbreak/exposure investigation
 Construction Risk Assessment before

© Joint Commission International


construction begins

4
Surveillance
 Passive surveillance
• Retroactive activities such as,
• reviewing medical records, culture results
(wound, blood, urine, etc.), various reports
(SSI summary after discharge, water tests,
sterilization indicators, sharps injury rates,
etc..)
• surgical antibiotic prophylaxis (see antibiotic

© Joint Commission International


stewardship)

5
Surveillance Strategy

 Risk-based
 Unit-based
 Pathogen-based
 Procedure-based

© Joint Commission International


6
Surveillance Methods

1. Total or universal surveillance

2. Targeted or focused surveillance

3. Prevalence survey

© Joint Commission International


7
When to use a targeted surveillance?

 High risk infections


 High volume procedures
 Preventable adverse outcomes
 Critical processes
 Infection rates pertain to specific devices, procedures,
care processes, employee issues

© Joint Commission International


 Large patient population and limited resources

8
Electronic Surveillance

 Data Mining – detect patterns and likely infections or


outbreaks; uses clinical, pharmacological, laboratory
data

© Joint Commission International


9
Collecting Data
 Definition of healthcare-associated infection related
with each target condition or area
 Review medical records
 Clinical symptoms and signs compatible with an
infection
 Conference with clinicians, nurses, and others
 Review medical records
 Confirm HAI
 Documentation
 Tabulation and analysis
 Reporting

© Joint Commission International


 Follow up

10
Numerator, Denominator, and Multiplier

½ X 1,000

© Joint Commission International


11
Denominators

 Population at risk
 Patient days / residents days
 Device days
– central line days
– ventilator days
– Foley catheter days UTI
 Procedures performed 5 infections/1,000 device days
 # patients discharged
CLABSI
10 infections/1,000 line days

© Joint Commission International


12
Numerators

 HAI cases-SSI, VAP, CLABSI, etc.


 Positive blood cultures
 Positive VRE in stool
 Positive MRSA in nares/axilla/groin
 Patients on vancomycin

© Joint Commission International


13
Analyzing Data

 Incidence = new cases x constant (1000)


population at risk

 Prevalence = existing cases x constant


population at risk

© Joint Commission International


14
Risk Stratification-Risk Adjustment

Surgical Site Infections


 Patients have different risks for acquiring HAI
– Host factor
– Preexisting risks (comorbidities, ASA score, etc.)
– Intra-operative variables (duration of surgery,
bleeding, body temperature, oxygenation, etc.)
– Sample size (too small)

© Joint Commission International


15
Standardized Infection Rate (SIR)
 Standardized Infection Rate (SIR)
= Observed SSI rate / SSI rate of standard population
(average rate)
OR
= Observed SSI number / Expected SSI number
 Example.
– Dr. Z’s SSI for cholecystectomy: 6
– Expected SSI in the standard population: 1.16

© Joint Commission International


SIR = 6/1.16 = 5.2* (> 1)
*Sample size may require Z-test

16
Collecting and Documenting Data
 Narrative
– E.g; A 34 year old male underwent an open
repair and internal fixation of right ankle
fracture. The wound became infected 5 days
later with S. aureus.
• Old fashioned?
• Difficult to aggregate at the end of the
surveillance

© Joint Commission International


• No visual impact

17
Collecting Data
 Graphic analytical analysis
– Bar graph

– Line graph

– Pie graph

© Joint Commission International


18
Measles

5 Index case
First generation case
4 Second generation case
Cases

3 Third generation case

2
1
0
14 3

20 9
23 2
26 5

17 6
17 6

14 3

9
-1
11 0

10
4
7

7
4
-1

-1
-2
-2

-1
-1

-2

-1

-1
1
2-
5-

5-
2-
29
8-

8-

© Joint Commission International


11
September October
Date of Onset
19
Blood Stream Infection Rates

20

© Joint Commission International


Surgical Site Infection Rates

21

© Joint Commission International


BSI Rate and Intervention

22

© Joint Commission International


Collecting Data; data sheet
 Computer soft ware
– Excel sheet

© Joint Commission International


23
Collecting Data; Dashboard

24

© Joint Commission International


Collecting Data:Dashboard with Trends

© Joint Commission International


25
Data Analysis and Use

 Timely
 Share the data
 Learn from it
 Plan for improvement

© Joint Commission International


26

Vous aimerez peut-être aussi